Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Trading Update

8 Jul 2020 07:00

RNS Number : 3154S
Medica Group PLC
08 July 2020
 

8 July 2020

 

Medica Group Plc

 

Trading Update

 

Medica Group Plc (LSE: MGP, "Medica" or the "Company"), the UK market leader in the provision of teleradiology services, announces a trading update for the six months ended 30 June 2020.

 

Medica expects revenue for H1 2020 to be £17.0 million, compared to £22.0 million in H1 2019, due to the impact of the COVID-19 pandemic on radiology reporting activity, as previously announced. Medica's cash position remains robust and, despite the decline in revenues, there has been limited impact on the Company's cash generation, with a cash balance of £20.0 million at 30 June 2020 compared to £16.5 million at 31 December 2019.

 

Further to the announcement on 20 May 2020, reporting activity has continued to improve towards levels experienced before the pandemic and the Company returned to profitability in June 2020. To note, Medica has not required any government funding to support its business and the Company has not furloughed any staff.

 

For NightHawk, the Company's out-of-hours service, reporting activity has returned to around 95% of the level experienced prior to the COVID-19 pandemic. The Company expects to maintain this level of activity following the ease of restrictions imposed by the UK government in an attempt to curb the spread of the virus, notwithstanding a return to national or regional lockdowns resulting from subsequent peaks of infection.

 

The Company's routine (elective) reporting has started to increase steadily and is now around 10% of the level experienced prior to the COVID-19 pandemic. Medica expects its routine reporting volumes to continue to increase in the coming months, as NHS hospitals work to process the substantial backlog of elective procedures and government restrictions are eased.

 

Despite the reduction in reporting activity during the period, capacity has strengthened and recruitment has been strong as radiologists realise the benefits of Medica's secure and reliable home-reporting capabilities. In addition, the pandemic has had a limited impact on the Company's ability to drive forward projects in support of the new strategy, which was announced in March 2020. Medica has also taken advantage of the reduction in workload to initiate an operational excellence programme and to accelerate training and implementation of new clinical protocols to improve the quality of its services.

 

Further to the announcement on 30 March 2020, Richard Jones will be joining Medica as Chief Financial Officer on 3 August 2020.

 

Dr. Stuart Quin, Chief Executive Officer of Medica, commented:

"Whilst demand for our services was significantly impacted during the period, particularly our routine service due to the suspension of elective procedures, we are encouraged to see a continuing improvement in activity. This is particularly evident for our Nighthawk service, with activity now similar to pre-COVID-19 levels. We continue to work closely with our clients to provide timely reporting of imaging for elective procedures as they actively manage waiting lists that have built up over the past months.

 

"I want to thank all involved at Medica who have ensured the high level of service we offer the NHS has been sustained during this challenging time. I recognise the professionalism and commitment shown by our reporters working in the front line and our team working hard to maintain our services from their homes. As a result, Medica has been able to quickly adapt and respond to client's needs, strengthening its position as a leader in the provision of teleradiology services."

 

Medica plans to provide an update on guidance for the full year and publish its financial results for the six months ended 30 June 2020 on 14 September 2020.

 

For further information, please contact:  

 

Medica Group Plc:

Roy Davis, Chairman

Stuart Quin, Chief Executive Officer

 

+44 (0)33 33 111 222

 

Investec Bank Plc

Sara Hale

Daniel Adams

 

+44 (0)20 7597 5970

FTI Consulting

Victoria Foster Mitchell

Robert Winder

 

+44 (0)20 3727 1000

 

About MEDICA

 

MEDICA is the UK market leader in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.

 

MEDICA has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with MEDICA. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.3 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk 

 

About Teleradiology

Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTRRMRTMTBMBRM
Date   Source Headline
1st Aug 20225:33 pmRNSHolding(s) in Company
1st Aug 20222:58 pmRNSIssue of Equity and Total Voting Rights
1st Aug 202212:13 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSTrading update and full year outlook
25th Jul 20222:30 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSBlock Listing Application
28th Jun 202212:46 pmRNSHolding(s) in Company
27th Jun 20221:58 pmRNSResult of AGM
27th Jun 20227:00 amRNSAGM Statement
27th May 20225:22 pmRNSNotice of AGM
19th May 20227:00 amRNSHolding(s) in Company
12th Apr 202211:29 amRNSPublication of Annual Report
4th Apr 20227:00 amRNSResults for the year ended 31 December 2021
9th Mar 20224:40 pmRNSSecond Price Monitoring Extn
9th Mar 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20224:35 pmRNSPrice Monitoring Extension
16th Feb 202211:22 amRNSHolding(s) in Company
4th Feb 20223:05 pmRNSNotification of Major Holdings
28th Jan 20222:02 pmRNSNotification of Major Holdings
27th Jan 20221:19 pmRNSNotification of Major Shareholdings
26th Jan 20227:00 amRNSTrading and Business Update
24th Jan 20228:00 amRNSHolding(s) in Company
7th Jan 20227:00 amRNSAppointment of Numis as Joint Broker
5th Jan 20223:21 pmRNSBlock listing Interim Review
30th Dec 20213:48 pmRNSIssue of Equity
20th Dec 20214:36 pmRNSPrice Monitoring Extension
20th Dec 20218:00 amRNSHolding(s) in Company
25th Nov 20218:00 amRNSHolding(s) in Company
2nd Nov 202110:01 amRNSDirector/PDMR Shareholding
29th Oct 20219:18 amRNSTotal Voting Rights
8th Oct 20217:00 amRNSIssue of Equity
29th Sep 20217:00 amRNSRecord Date for Dividend – Correction
27th Sep 20217:00 amRNSInterim results for the six months to 30 June 2021
17th Sep 20211:47 pmRNSHolding(s) in Company
7th Sep 20217:00 amRNSCapital Markets Day
26th Aug 202110:17 amRNSHolding(s) in Company
17th Aug 202111:20 amRNSHolding(s) in Company
30th Jul 20217:00 amRNSIssue of Equity and Total Voting Rights
22nd Jul 20217:00 amRNSTrading and business update
8th Jul 20219:28 amRNSHolding(s) in Company
5th Jul 202110:49 amRNSBlock Listing Application
22nd Jun 20211:45 pmRNSDirector/PDMR Shareholding
21st Jun 20217:00 amRNSDirector/PDMR Shareholding
16th Jun 20211:00 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
15th Jun 20217:40 amRNSDirector Declaration
15th Jun 20217:00 amRNSMedica appoints Barbara Moorhouse as NED
11th Jun 20214:34 pmRNSDirector/PDMR Shareholding
9th Jun 20219:05 amRNSHolding(s) in Company
4th Jun 20211:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.